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Introduction
Patients undergoing cardiopulmonary bypass (CPB) surgery
frequently develop systematic inflammatory response
syndrome, ranging from mild to severe complications such as
pericardial, pleural and/or abdominal effusion, liver enlarge-
ment and edema. These complications are characterized by
CLS, capillary leak syndrome; CPB, cardiopulmonary bypass; CRP, C-reactive protein; EDTA, ethylenediaminetetracetic acid; Ig, immunoglobulin;
IL, interleukin; LFA-1, leukocyte function associated molecule-1; MOD, multiple organ dysfunction; POEE, postoperative effusions and edema;
sE-selectin, soluble endothelial-selectin; sL-selectin, soluble leukocytic-selectin; Th1/2, T-helper type 1/2; TNF, tumor necrosis factor.
Abstract
Aim: Postoperative effusions and edema and capillary leak syndrome in children after cardiac surgery
with cardiopulmonary bypass constitute considerable clinical problems. Overshooting immune
response is held to be the cause. In a prospective study we investigated whether preoperative immune
status differences exist in patients at risk for postsurgical effusions and edema, and to what extent
these differences permit prediction of the postoperative outcome.
Methods:  One-day preoperative serum levels of immunoglobulins, complement, cytokines and
chemokines, soluble adhesion molecules and receptors as well as clinical chemistry parameters such
as differential counts, creatinine, blood coagulation status (altogether 56 parameters) were analyzed in
peripheral blood samples of 75 children (aged 3–18 years) undergoing cardiopulmonary bypass
surgery (29 with postoperative effusions and edema within the first postoperative week).
Results: Preoperative elevation of the serum level of C3 and C5 complement components, tumor
necrosis factor-α, percentage of leukocytes that are neutrophils, body weight and decreased
percentage of lymphocytes (all P < 0.03) occurred in children developing postoperative effusions and
edema. While single parameters did not predict individual outcome, >86% of the patients with
postoperative effusions and oedema were correctly predicted using two different classification
algorithms. Data mining by both methods selected nine partially overlapping parameters. The
prediction quality was independent of the congenital heart defect.
Conclusion: Indicators of inflammation were selected as risk indicators by explorative data analysis.
This suggests that preoperative differences in the immune system and capillary permeability status
exist in patients at risk for postoperative effusions. These differences are suitable for preoperative risk
assessment and may be used for the benefit of the patient and to improve cost effectiveness.
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increased capillary permeability, a shift of fluid and protein
from the intravascular to the interstitial space and may further
progress into hypovolemia, massive generalized edema, acute
respiratory distress syndrome, or even capillary leak syndrome
(CLS) or multiple organ dysfunction (MOD) or failure, with a
substantial morbidity and mortality [1–4]. Although the inci-
dence of postoperative effusion in children is substantial
(>25%) its etiology is yet not well understood. Nearly 97,000
(Germany 1998) [5] and 800,000 (USA 1996, American
Heart Association, http://www.amheart.org) patients undergo
CPB surgery annually (~10% for congenital heart disease
[5]), hence postoperative complications constitute a signifi-
cant clinical problem.
The extensive contact between heparin anticoagulated blood
and foreign surfaces of the extracorporal circuit during CPB,
in combination with anesthetics and other medication used
during and after surgery stimulates the immune system
[2,6–8]. Cytokines play a key role in the inflammatory
cascade associated with CPB [7,9]. Tumor necrosis factor-α
(TNF-α), interleukin (IL)-6 and IL-8 (proinflammatory
cytokines) may contribute to myocardial dysfunction and
increased apoptosis [10] and increased neutrophil activation
[11], and IL-10 may contribute to immune depression [12]
and increased susceptibility to infection.
There is some evidence that patients who later develop post-
operative complications may be identified in the early peri-
operative or even in the preoperative period [13–18]. Several
scoring systems use clinical and/or laboratory data acquired
during or after therapy to predict cardiac patients outcome
[13,14] with informative serum parameters like soluble
endothelial (sE)-selectin for restenosis [16] or perioperative C-
reactive protein (CRP) [15], lactate [3], IL-6 [17] or altered
blood coagulation [19] after open heart surgery. Recently, pre-
diction of postoperative complications based on preoperative
parameters were published [18,20]. The prediction of patients
at risk for postoperative complications is important for the indi-
vidual preoperative prophylactic treatment. Preoperative pre-
diction is based on the hypothesis that the primed immune
system amplifies the immune response to cardiosurgical
trauma; for example, TNF-α or fibronectin primed neutrophils
respond more strongly to stimulation in vitro [21,22]. Priming
in the patients may be caused by an allergic/atopic predisposi-
tion [1,6,15] but can also be a result of fresh or reactivated
viral infection [1]. A recent study in this journal indicates
gender as a predisposing factor for MOD in children [23].
In a recent study we showed that children who suffered from
postoperative effusions and edema (POEE) are, 24 hours
before surgery, already exhibiting altered antigen expression
on leukocytes, by which risk assessment would be possible
using discriminant analysis [18]. Based on these results we
hypothesized that children at risk of POEE have an altered
preoperative level of markers of immunoactivation, allergic/
atopic predisposition or T-helper type 2 (Th2) phenotype,
which may be used as predictors for risk assessment. In addi-
tion, we also included readily available standard laboratory
parameters in order to test predictive strength. The advan-
tage of a serological classifier over that based on antigen
expression data by flow cytometry is that these data and
methods are accessible for virtually all clinical facilities and
are easily standardized. In the present study we show that
children at risk of POEE are already predisposed to the con-
dition and can be predicted from these data.
Methods
Study groups
This prospective non-randomized study was conducted
between November 1995 and May 2001 following approval
by the ethical committee of the medical faculty at the Univer-
sity of Leipzig, Germany. A total of 75 patients who under-
went cardiac surgery with CPB were analyzed [inclusion
criteria: aged 3–18 years, body weight >12 kg; exclusion cri-
teria: missing informed consent of parents, palliative cardiac
surgery (e.g. if single ventricle circulation was the aim of
surgery, (Glenn, Fontan or total cavopulmonary connection
[TCPC]). The surgical procedures included were: closure of
atrial septal defect (n = 39) or ventricular septal defect
(n = 11); replacement of pulmonary valve by an allogeneic
heart valve (n = 18); resection of an aortic subvalvular steno-
sis resulting from a subaortic membrane or fibrous cap
(n = 6); correction of tetralogy of Fallot (n = 1). All children
received similar anesthesia, medication and intraoperative
and postoperative care and CPB as detailed elsewhere [2].
After delivery to the intensive care unit postoperatively, the
incidence of pericardial-, pleural- and/or abdominal-effusion
was monitored by echocardiography, chest X-ray or sonogra-
phy. If patients developed detectable effusions after removal
of the thoracic drainage (which was usually one day after
surgery) until discharge they were allocated into the POEE
group (n = 29), or into the non-POEE group (no effusion,
n = 46). As evaluated visually, all POEE patients had edema
of the face and/or hands and/or feet. Incidence of edema was
not used for POEE discrimination because quantitative mea-
sures of extravascular body fluid volume (such as scintigraphy
following labelling of the extravascular fluid by radiolabelled
sulphide or bromide) were ethically not feasible in children.
Massive generalized edema, CLS or MOD as defined by
Seghaye et al. [24] was not observed in any of the patients.
However, 65% of the POEE patients fulfilled at least one
MOD criterion as defined by Trotter et al. [23]. Postpericar-
diotomy syndrome with effusions and fever of non-infectious
origin within a week, or later, of surgery [25] was not present
in any of the patients.
Complement, cytokines, soluble adhesion molecules
Blood was obtained one day (median: 20 hours) before
surgery in untreated tubes as well as in ethylenediamine-
tetracetic acid (EDTA) and heparin tubes, centrifuged at
2800 g for 10 min at 4°C and the supernatant was collected.
Urine was sampled in untreated tubes. Within 1 hour afterCritical Care    June 2002 Vol 6 No 3 Bocsi et al.
collection, serum, EDTA-plasma and urine samples were
stored in aliquots at –80°C. The concentration of the comple-
ment components (C3, C4, C5, C1-inhibitor, C3d) and
immunoglobulin (Ig)G2 was determined by radial immune dif-
fusion (The Binding Site, Heidelberg, Germany) with serum or
EDTA-plasma (C3d) and total hemolytic complement CH100
by lysis of antibody-coated sheep erythrocytes (The Binding
Site). All other parameters were quantified using enzyme-
linked immunosorbent assay [IgE, interleukin (IL)-1β, TNF-α,
interferon-γ, RANTES, histamine: Beckman-Coulter, Krefeld,
Germany; IL-4, IL-10, IL-13, soluble intracellular adhesion
molecule-1 (sICAM-1), platelet endothelial cell adhesion
molecule-1 (PECAM): Bender MedSystems, Vienna, Austria;
IL-5, IL-6 high sensitivity, IL-10 high sensitivity, IL-12
p40/p70, soluble leukocytic (sL)-selectin, sE-selectin: R&D
Systems GmbH, Wiesbaden, Germany; IL-2, IL-2-receptor,
serum and urine neopterin: DPC Biermann GmbH, Bad
Nauheim, Germany; IL-4 high sensitivity, IL-11: Natutec,
Frankfurt, Germany; IL-12 p70, IL-13: Biozol Diagnostica Ver-
trieb GmbH, Eching, Germany; C5a: Behringwerke AG,
Marburg, Germany]. The complement fragment ratios
C3d/C3, C5a/C5 and immunoglobulin ratio IgE/IgG2, were
calculated as measures for complement activation and
Th2/Th1 imbalance, respectively. Additionally, routine labora-
tory and clinical chemistry parameters were determined (cell
count, differential blood count, CRP, creatinine, electrolytes,
protein, hematocrit, blood coagulation parameters). In total
56 parameters were analyzed per patient including age,
gender and body weight.
Statistical analysis
Data are displayed as mean ± standard deviation (SD).
Between-group comparison was undertaken by unpaired Stu-
dent’s t-test or Mann-Whitney U-test as appropriate [Statisti-
cal Program for Social Sciences Version 8.0 (SPSS), Knowl-
edge Dynamics, Canyon Lake, TX]. Discrimination of patients
into the POEE and control group was tested by data pattern
analysis using two different methods as detailed [18]. Classi-
fication for individual risk assessment was performed by step-
wise multivariate discriminant analysis using SPSS. This
classifier was optimized by increasing the F-probability fol-
lowed by determination of the unstandardized canonical dis-
criminant function. Missing data were substituted by column
means, if necessary. No more than one value per patient was
extrapolated. In parallel, the triple matrix data pattern analyzer
CLASSIF1 [18] was used as an algorithmic data mining
approach. With CLASSIF1 no replacement of missing data
values and no mathematical assumptions on parameter distri-
butions are required.
Results
Clinical data are comparable in the control group and among
those patients at risk for POEE. Data on patients and surgical
parameters were grouped according to the clinical outcome
in non-POEE and POEE groups (Table 1). Patients with
POEE were of similar age and gender, while duration of
surgery + anesthesia and extracorporal circulation were
longer. Other parameters, including priming and infusion
volume, duration of hypothermia and hemofiltration volume
(i.e. volume of fluid that has been removed from the blood to
accomplish normal hematocrit values at the end of surgery)
were not significantly different (not shown). POEE patients
had a higher body weight (Table 2) and stayed in hospital one
day longer after surgery. All patients were discharged in good
condition.
Patients at risk of POEE exhibited signs of inflammation. Chil-
dren with POEE had preoperatively significantly higher levels
Table 1
Clinical and surgical data of POEE and non-POEE patients (means ± SD)
Surgical parameters and patient data Non-POEE (n = 46) POEE (n = 29) P-value
Age (years) 8.8 ± 4.4 9.8 ± 3.6 0.23*
Body weight (kg) 27.3 ± 11.9 35.0 ± 13.7 0.009+
Gender (F/M) 23/23 16/13 NS†
Aortic cross-clamping (min) 34.0 ± 27.8 47.7 ± 34.7 0.13*
CPB (min) 65.9 ± 37.1 98.4 ± 62.9 0.04+
Surgery + anesthesia (min) 177.1 ± 58.5 213.7 ± 98.6 0.10*
Reperfusion (min) 18.7 ± 18.2 25.4 ± 29.0 0.54+
Hypothermia (minimal temperature °C) 30.6 ± 3.1 30.7 ± 2.8 0.80*
Length of stay on ICU (days) 1.9 ± 0.9 2.9 ± 4.1 0.25+
Mechanical ventilation on ICU (hours) 10.1 ± 5.0 11.7 ± 6.6 0.36+
Discharge (days after surgery) 9.4 ± 5.2 10.7 ± 4.7 0.031+
†Chi-squared test, NS = not significant, *two-tailed Student’s t-test, +Mann-Whitney U-test. CPB, cardiopulmonary bypass; ICU, intensive care
unit; POEE, postoperative effusions and edema.of several complement components, TNF-α, neutrophilic
granulocyte count and percentage (Table 2). These data indi-
cate increased immune activation/alteration of at risk patients.
At risk patients can be identified preoperatively by data clas-
sification. The use of single parameters for individual risk
assessment is insufficient, as most data for the POEE
patients (>75%) showed significant overlap with non-POEE
patients. The highest discrimination by a single parameter
was obtained with C3 (specificity: 55%; sensitivity: 67%). On
multivariate analysis, however, the majority of patients from
both groups were correctly classified irrespective of the clas-
sification program applied (SPSS/CLASSIF1; specificity:
80.4%/97.8%; sensitivity: 86.2%/72.4%; and negative:
90.2%/84.9%; and positive: 73.5%/91.3% predictive values)
(Table 3). Only nine of the 56 parameters were required for
these classifications (Table 4). Five parameters were unique
to each classifier, while increased C5 and sL-selectin serum
concentration, increased neutrophil percentage or count and
elevated hematocrit were selected by both classification
methods as discriminant factors. Misclassifications were not
assigned to a certain type of cardiac defect (Chi-squared
test; see also Table 3, classification of subgroups), indicating
that POEE prediction is independent of the surgery per-
formed. This interpretation is also supported by the result that
atrial septal defect patients and the patients who underwent
other types of surgeries were both classified with nearly iden-
tical sensitivity, specificity and negative and positive predic-
tive values (Table 3).
Conclusion
There are two major findings of our study. First, that cardiac
surgery patients with problematic postoperative disease
already exhibit elevated serum concentration of complement
components C3 and C5, TNF-α and neutrophils (count and
percentage) one day preoperatively. Second, that preopera-
tive risk assessment based on serological and clinical chem-
istry data is possible, with high levels of accuracy.
The preoperative predictive risk assessment represents a
clear advantage over assays relying on data acquired during
or after cardiac intervention. Preoperative differences, as
selected by our explorative data analysis, indicate a preopera-
tive activation of the immune system, for example, by a sub-
clinical inflammatory response [1,15], an atopic/allergic
predisposition or a condition resulting from the congenital
Available online http://ccforum.com/content/6/3/226
Table 2
Twenty-four hour preoperative serum parameters in postoperative non-POEE and POEE patients (means ± SD). From the 56
determined parameters, those selected by one of the classification programs or exhibiting significant differences are shown
Parameter (units) Non-POEE (n) POEE (n) P-value Classifier
C1-inhibitor (mg/l) 937 ± 270 (46) 888 ± 342.0 (29) 0.49* C
C3 (mg/l) 1329 ± 200 (46) 1467 ± 325.0 (29) 0.022* C
C5 (mg/l) 128.7 ± 54.3 (46) 177.4 ± 87.4 (28) 0.001+ C
C5a (mg/l) 0.45 ± 0.36 (46) 0.73 ± 1.08 (29) 0.09+ S
C5a/C5-ratio 0.38 ± 0.29 (46) 0.51 ± 0.72 (28) 0.39+ S
TNF-α (ng/l) 36.2 ± 118.8 (45) 63.5 ± 222.4 (29) 0.028+
IL-10 (ng/l) 1.50 ± 4.89 (46) 3.95 ± 11.15 (29) 0.18+ S
sL-selectin (µg/l) 1299 ± 294 (44) 1434 ± 37 (24) 0.27* S,C
% lymphocytes  41.7 ± 11.0 (46) 34.9 ± 10.1 (29) 0.010*
% neutrophils 46.7 ± 11.3 (46) 54.9 ± 11.8 (29) 0.005* S
Neutrophils (cells/µl) 3506 ± 1500 (45) 4219 ± 1490 (27) 0.086* C
Monocytes (cells/µl) 579 ± 219 (45) 634 ± 242 (27) 0.23* S
Eosinophils (cells/µl) 218 ± 195 (45) 206 ± 226 (27) 0.83+ C
Serum protein (g/l) 72.3 ± 5.0 (41) 70.9 ± 5.9 (28) 0.27* S
Hematocrit (%) 37.3 ± 5.0 (44) 40.2 ± 10.8 (27) 0.14+ S,C
Partial thrombin time (s) 35.9 ± 3.7 (45) 35.2 ± 4.6 (28) 0.56* C
Potassium (mmol/l) 4.2 ± 0.3 (45) 4.1 ± 0.5 (28) 0.55* C
Body weight (kg) 27.3 ± 11.9 (46) 35.0 ± 13.7 (29) 0.008+ S
*Two-tailed Student’s t-test, +Mann-Whitney U-test. Parameter used by S = SPSS classifier, C = CLASSIF1 classifier or S,C= both classifiers.
n = number of patients. IL, interleukin; POEE, postoperative effusions and edema; sL-selectin, soluble leukocytic-selectin; TNF-α, tumor necrosis
factor-alpha.heart disease [26,27]. In contrast to the recent report that
MOD in children is gender related [23], gender was not a
predisposing factor in our study.
Inflammatory response
Preoperative serological alteration or activation indicates spe-
cific pathobiochemical problems. The parameters selected by
the two classifiers in this study indicate increased POEE risk
for patients with elevated inflammatory response by increased
complement and neutrophil activation and coagulation (see
Table 4). In different cardiac situations, CRP [15], sE-selectin
[16], sICAM-1 and neutrophil adhesion molecule expression
[28,29] have been discussed as risk factors. As already sug-
gested by others [19], preoperatively altered blood coagula-
tion values such as partial thrombin time were found to be
prognostic for postoperative blood loss. Fibrinogen and fibrin
are ligands for Mac-1 [30], inducing neutrophil, monocyte or
resting platelet activation. Our study indicates this activation
by elevated sL-selectin level as an important discriminant
parameter. CPB is associated with major qualitative and
quantitative alterations of humoral pathways and changes in
leukocyte subsets, generating a systemic inflammatory
response [2,4,7,31] with interactions between vascular
endothelium, platelets and leukocytes including signal
exchanges, adhesion molecule expression and secretion of
cytokines or chemokines in a multi-step process. Patients
with an altered immune profile before surgery might show a
more pronounced or sustained immune response after
surgery. In an unstimulated immune system, CPB exposure
constitutes the initial stimulus that might prime the system for
postoperative complications [32]. In patients with a primed or
predisposed immune profile, CPB as the second stimulus
may facilitate an enhanced immune response, which, in turn,
may lead to POEE, CLS or multiple organ failure.
The main discriminators of at risk patients (elevated levels of
complement and activated complement components, TNF-α
and IL-10) indicate the significance of complement system
and monocyte activation. Activated monocytes liberate TNF-α
and IL-10 as important modulators of the inflammatory
response. TNF-α stimulates human vascular endothelium,
thus mediating leukocyte recruitment to sites of inflammation.
IL-10 release is specific to CPB surgery [7] and patients with
POEE or MOD release higher quantities of IL-10 [7,23].
Increased IL-10 release as an indicator of MOD or effusions
is also supported by the finding that perioperative methyl-
prednisolone administration, that enhances IL-10 release
during CPB surgery in adults [33], aggravates postoperative
effusions and bleeding in children with postcardiotomy syn-
drome [34]. Elevated preoperative IL-10 concentration was a
risk factor in our patients. An observation that contrasts with
the finding that children with MOD had reduced IL-10 serum
levels [23] prior to CPB. Patients from our study had no
gender-related differences in any of the analyzed laboratory
parameters. We have no explanation for this discrepancy, but
differences in the age distribution and the congenital heart
diseases of patients included in our study, as compared to
Trotter et al. [23], may play a role.
Severe allergic reactions with cardiac surgery [6,34] and aller-
gic predisposition in adults at risk for cardiovascular death have
been reported [35]. The interpretation of allergic/atopic predis-
position in POEE risk was indicated by our recent observation
of elevated leukocyte function asscoiated molecule-1 (LFA-1)
expression on leukocytes of at risk patients [18], as LFA-1
expression is increased on leukocytes of atopic children [36].
We reported earlier that patients at risk for POEE also had
increased preoperative histamine and eosinophil counts,
among others [7,29]. The results from the present study do not
clearly support the hypothesis of risk prevalence for atopic/
allergic patients because only few of the selected markers
could indicate an atopic/allergic predisposition (e.g. TNF-α and
IL-10). We conclude from these differences that both
increased inflammatory status and allergic/atopic predisposi-
tion are predictors of increased POEE in children.
Clinical implications
Taken together, the data indicate at least three risk groups for
pediatric POEE. Risk patients might have: (i) latent infection;
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Table 3
Classification of POEE and non-POEE patients (confusion
matrices) of 24 h preoperative serological parameters by the




Clinical outcome (n) POEE POEE
SPSS
Non-POEE (all patients) 46 80.4 19.6
(ASD) (25) (80.0) (20.0)
(residual) (21) (81.0) (19.0)
POEE (all patients) 29 13.8 86.2
(ASD) (14) (14.3) (85.7)
(residual) (15) (13.3) (86.7)




Non-POEE (all patients) 46 97.8 4.3*
(ASD) (25) (96.0) (4.0)
(residual) (21) (100.0) (4.7)*
POEE (all patients) 29 27.6 72.4
(ASD) (14) (35.7) (64.3)
(residual) (15) (20.0) (80.0)
Negative/positive predictive values 84.9 91.3
(ASD) (82.7) (90.0)
(others) (87.5) (92.3)
Classification result shown separately for ASD patients or the residual
patients applying the identical classification algorithms as for the total
group of patients. *Simultaneous classification non-POEE/POEE for
one patient increases line sum above 100%. ASD, atrial septal defect;
POEE, postoperative effusions and edema.(ii) atopic/allergic predisposition; or (iii) immune alterations as
a result of the congenital heart disease. These hypotheses
have to be further scrutinized by future studies.
Because children with postoperative complications usually
have a longer stay on the ICU, a longer period of mechanical
ventilation and stay longer in hospital, preoperative risk
assessment is of clear therapeutic advantage and can be
cost-effective by reducing any stay in intensive care. By
prospective classification, up to 86% of the patients at risk
were correctly identified preoperatively. In view of the fact
that such predictions were not possible at all until now, these
predictive values are promising. However, the classifier will
be optimized by increasing the number of patients enrolled in
studies and by combining this serological classifier with addi-
tional parameters such as flow-cytometric data [18].
Individual risk assessment before cardiac surgery of this type
might open new ways to develop individual treatment strate-
gies with two possible clinical consequences: first, postpone-
ment of surgery until the normalization of clinical parameters
(e.g. elimination of stress or a latent infection); and, second,
application of individual prophylaxis [31] in the case of
endogenous reasons for immune system alterations
[28,34,35]. The hypothesis that postponement or individual




Preoperative parameters and coefficients for prediction of postoperative cardiac surgery outcome by the SPSS and CLASSIF1
classifiers
SPSS classifier CLASSIF1 classifier
Parameter (pi) Coefficients (ci)* Parameters POEE patients classification mask**
C1-Inhibitor –
C3 +
C5 0.005105 C5 +
C5a/C5-ratio 0.788609
IL-10 0.086488





Hematocrit 0.06021 Hematocrit +
Serum protein –0.136055
Body weight 0.067000
Partial thrombin time –
Potassium –
(Constant –0.939490)
Formula of the discriminant function: *Constant + Σ
i = 9
i = 1
(pi × ci), resulting value <0, non-POEE risk, if >0, POEE risk.
pi = measured parameter values; ci = classifier coefficients. **Parameter on average above (+) or below (–) the 25–75% percentile thresholds for
C1-inhibitor: 300/377 mg/l (25%/75%); C3: 1181/1456 mg/l; C5: 100/131 mg/l; sL-selection: 1102/1501 µg/l, neutrophil count:
3900/5520 cells/µl; eosinophil count: 85/269 cells/µl; hematocrit: 34.0/39.8%; partial thrombin time: 33.3/37.9 s; K+: 4.04/4.38 mmol/l. Non-
POEE patients have, on average, all parameters unchanged (0) between the 25–75% percentile thresholds. Unknown patients are classified
according to the highest number of positional coincidences, with the POEE or the non-POEE patients classification mask.
Key messages
• The development of postoperative edema and effusion
(POEE) in children after cardiopulmonary bypass
surgery can be predicted preoperatively.
• POEE develops on the background of a pre-existing
immune activation.
• The immune activation has cellular (neutrophil,
eosinophil, monocyte counts, hematocrit) and humoral
(C1-inhibitor, C3, C5a/C5, IL-10, sL-selectin, partial
thrombin time, serum potassium) components.
• Preoperative normalization of the immune activation
status has the potential of decreasing the intensive
care treatment and the overall level of postoperative
complications.The proposed serological classifier should permit individual
risk assessment in hospitals with lower patient numbers. It is
planned to set up and optimize an on-line classifier for POEE
risk assessment on the internet. One of the practical conse-
quences of this would be that diseases could be categorized
at institutions where no sufficient database can be generated
in a reasonable time period. Risk assessments for patients at
other institutions can be calculated for test purposes using
the indicated SPSS classifier formula (Table 4). Each
required parameter value is multiplied with a local data cor-
rection factor. The local data correction factor is obtained as
a ratio between the parameter mean from non-POEE patients
from Table 2 of this study and the mean of the respective
parameter from the local non-POEE group of 20 to 40 com-
plication-free patients. The local data correction factor for the
establishment of the individual patient’s triple matrix for the
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